These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Filed by the Registrant
|
ý
|
|
Filed by a Party other than the Registrant
|
o
|
|
Check the appropriate box:
|
|
|
o
|
Preliminary Proxy Statement
|
|
o
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
ý
|
Definitive Proxy Statement
|
|
o
|
Definitive Additional Materials
|
|
o
|
Soliciting Material Pursuant to Section 240.14a-12
|
|
ý
|
No fee required.
|
|
o
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
(5)
|
Total fee paid:
|
|
o
|
Fee paid previously with preliminary materials:
|
|
o
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
(1)
|
Amount previously paid:
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
(3)
|
Filing Party:
|
|
(4)
|
Date Filed:
|
|
1.
|
To consider and vote upon a proposal to elect
seven
directors to serve on the Board of Directors of the Company until the Annual General Meeting of Shareholders of the Company in
2021
, or the
2021
Meeting;
|
|
2.
|
To consider and vote upon a proposal to elect
seven
directors to serve on the Board of Directors of Greenlight Reinsurance, Ltd. until the
2021
Meeting, which, pursuant to the Company’s Third Amended and Restated Memorandum and Articles of Association, or the Articles, is required to be considered by the shareholders of the Company;
|
|
3.
|
To consider and vote upon a proposal to elect
five
directors to serve on the Board of Directors of Greenlight Reinsurance Ireland, Designated Activity Company until the
2021
Meeting, which, pursuant to the Articles, is required to be considered by the shareholders of the Company;
|
|
4.
|
To consider and vote upon an amendment to increase the number of Class A ordinary shares available for issuance under the Company’s amended and restated stock incentive plan from 5.0 million Class A ordinary shares to 8.0 million Class A ordinary shares;
|
|
5.
|
To consider and vote upon a proposal to ratify the appointment of BDO USA, LLP as the independent auditors of the Company for the fiscal year ending
December 31, 2020
;
|
|
|
By Order of the Board of Directors,
|
|
|
|
/s/ Simon Burton
|
|
|
|
Simon Burton
|
|
|
|
Chief Executive Officer
|
|
|
|
September 8, 2020
|
|
|
|
Grand Cayman, Cayman Islands
|
|
|
|
Page
|
|
•
|
29,366,219
Class A ordinary shares, par value $0.10 per share; and
|
|
•
|
6,254,715
Class B ordinary shares, par value $0.10 per share.
|
|
•
|
enter a new vote by telephone, over the Internet or by signing and returning another proxy card at a later date;
|
|
•
|
file a written revocation with the Secretary of the Company at our address set forth above;
|
|
•
|
file a duly executed proxy bearing a later date; or
|
|
•
|
appear in person at the Meeting and vote in person.
|
|
Name
|
|
Age
|
|
Position
|
|
Director Since
|
|
Alan Brooks
(1)(3)(4)
|
|
73
|
|
Director
|
|
2004
|
|
Simon Burton
(3)
|
|
50
|
|
Director, Chief Executive Officer
|
|
2017
|
|
David Einhorn
(3)
|
|
51
|
|
Chairman
|
|
2004
|
|
Leonard Goldberg
(3)
|
|
58
|
|
Director
|
|
2005
|
|
Ian Isaacs
(2)(4)
|
|
65
|
|
Director
|
|
2008
|
|
Bryan Murphy
(1)(2)(3)
|
|
75
|
|
Director
|
|
2008
|
|
Joseph Platt
(1)(2)(4)(5)
|
|
72
|
|
Director
|
|
2004
|
|
Name and Position
|
Dollar Value ($)
|
Number of Class A Ordinary Shares
(2)
|
|
Non-Executive Director Group
(1)
|
$105,000
|
10,116
|
|
Name
|
|
Audit Committee
|
|
Compensation Committee
|
|
Nominating and Corporate Governance Committee
|
|
Underwriting Committee
|
|
Alan Brooks
(1)
|
|
X*
|
|
|
|
X
|
|
X
|
|
Simon Burton
|
|
|
|
|
|
|
|
X
|
|
David Einhorn
|
|
|
|
|
|
|
|
X
|
|
Leonard Goldberg
|
|
|
|
|
|
|
|
X
|
|
Ian Isaacs
|
|
|
|
X*
|
|
X
|
|
|
|
Frank Lackner
(2)
|
|
|
|
|
|
|
|
|
|
Bryan Murphy
(3)
|
|
X
|
|
X
|
|
|
|
X*
|
|
Joseph Platt
(4)
|
|
X
|
|
X
|
|
X*
|
|
|
|
Hope Taitz
(5)
|
|
|
|
|
|
|
|
|
|
Total Meetings in 2019
|
|
4
|
|
5
|
|
4
|
|
4
|
|
Director
|
|
Independent
|
|
Material Transactions and Relationships
|
|
Alan Brooks
|
|
Yes
|
|
None
|
|
Simon Burton
|
|
No
|
|
Chief Executive Officer of the Company
|
|
David Einhorn
|
|
No
|
|
President of Greenlight Capital, Inc. and DME Advisors
|
|
Leonard Goldberg
|
|
Yes
|
|
Former Interim Chief Executive Officer of the Company
|
|
Ian Isaacs
|
|
Yes
|
|
None
|
|
Frank Lackner
|
|
Yes
|
|
None
|
|
Bryan Murphy
|
|
Yes
|
|
None
|
|
Joseph Platt
|
|
Yes
|
|
None
|
|
Name
|
|
Age
|
|
Position
|
|
Position Since
|
|
Simon Burton*
|
|
50
|
|
Director, Chief Executive Officer
|
|
2017
|
|
Tim Courtis
|
|
59
|
|
Chief Financial Officer
|
|
2006
|
|
Brendan Barry
|
|
48
|
|
Chief Underwriting Officer
|
|
2011
|
|
Patrick O’Brien
|
|
51
|
|
Chief Executive Officer, GRIL
|
|
2017
|
|
Laura Accurso
|
|
44
|
|
General Counsel and Corporate Secretary
|
|
2016
|
|
Thomas Curnock
|
|
49
|
|
Chief Risk Officer
|
|
2016
|
|
Neil Greenspan
|
|
53
|
|
Chief Accounting Officer
|
|
2018
|
|
Name
|
|
Fees Earned or
Paid in Cash ($) |
|
Stock Awards ($)
(3)
|
|
Total ($)
|
|
Alan Brooks
|
|
90,000
|
|
105,000
|
|
195,000
|
|
Leonard Goldberg
(1)
|
|
35,000
|
|
105,000
|
|
140,000
|
|
Ian Isaacs
|
|
70,000
|
|
105,000
|
|
175,000
|
|
Frank Lackner
|
|
70,000
|
|
105,000
|
|
175,000
|
|
Bryan Murphy
(2)
|
|
125,970
|
|
105,000
|
|
230,970
|
|
Joseph Platt
|
|
—
|
|
175,000
|
|
175,000
|
|
Hope Taitz
(4)
|
|
42,703
|
|
105,000
|
|
147,703
|
|
(1)
|
During 2014 it was agreed between the Compensation Committee and Mr. Goldberg, that as a past NEO, Mr. Goldberg will receive reduced director compensation related to certain underwriting losses experienced in prior underwriting years. As such, Mr. Goldberg’s annual retainer was reduced by $35,000.
|
|
(2)
|
The $
125,970
includes €
50,000
that Mr. Murphy earned as compensation for his services as a director for GRIL. Such amount reported is based on an average conversion rate for
2019
, which was $
1.1194
United States dollars for each Euro.
|
|
(3)
|
All stock awards were granted under our stock incentive plan. The value reported above in the “Stock Awards” column is the aggregate grant date fair value of the awards granted in
2019
, determined in accordance with FASB ASC Topic 718, “Compensation-Stock Compensation”. Assumptions used in the calculation of these amounts are included in Note 11 of the Notes to Consolidated Financial Statements in our Company’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2019
. The number of restricted Class A ordinary shares issued as stock awards to each of Messrs. Brooks, Goldberg, Isaacs, Lackner, Murphy, Platt and Ms. Taitz during
2019
was
10,116
,
10,116
,
10,116
,
10,116
,
10,116
,
16,860
and
10,116
, respectively. These shares remained unvested as of
December 31, 2019
, other than Ms. Taitz’s shares which were forfeited in connection with her resignation from our Board and the Greenlight Re board of directors on August 9, 2019.
|
|
(4)
|
Due to Ms. Taitz’s resignation from our Board and the Greenlight Re board of directors, Ms. Taitz’s fees were paid on a pro-rata basis.
|
|
•
|
Simon Burton
, Chief Executive Officer;
|
|
•
|
Tim Courtis
, Chief Financial Officer;
|
|
•
|
Brendan Barry
, Chief Underwriting Officer;
|
|
•
|
Patrick O’Brien
, Chief Executive Officer, GRIL; and
|
|
•
|
Laura Accurso
, General Counsel and Corporate Secretary.
|
|
•
|
base salary;
|
|
•
|
bonuses; and
|
|
•
|
equity-based compensation.
|
|
•
|
the individual’s years of experience;
|
|
•
|
the functional role of the individual’s position;
|
|
•
|
the level of the individual’s responsibility;
|
|
•
|
our ability to replace the individual; and
|
|
•
|
to the extent applicable, the limited number of well-qualified candidates available in or willing to relocate to the Cayman Islands.
|
|
Actual RODE
|
|
Amount Credited to Quantitative Bonus Pool
|
|
Equal to or less than Risk Free Rate
|
|
Zero
|
|
Between Risk Free Rate and Target RODE
|
|
The sum of all employees’ target quantitative bonuses multiplied by a fraction, the numerator of which equals the actual RODE minus the risk free rate, and the denominator of which equals the target RODE minus the risk free rate.
|
|
Greater than Target RODE
|
|
The sum of all employees’ target quantitative bonuses plus 10% multiplied by the excess of actual RODE over target RODE multiplied by deployed equity.
|
|
Greater than Target RODE + 5%
|
|
In addition to the bonus calculated above, an additional bonus pool will be created equal to 10% multiplied by the excess of actual RODE over (target RODE + 5%) multiplied by deployed equity.
|
|
•
|
Monitor and manage overall enterprise risk and profitability;
|
|
•
|
Manage the growth and development of our underwriting teams and oversee senior personnel hiring to ensure successful longer-term succession;
|
|
•
|
Manage the evaluation and identification of new core areas of underwriting and strategic opportunities;
|
|
•
|
Lead the development of overall corporate strategy and business development; and
|
|
•
|
Provide consistent and appropriate communications to the Board of Directors and shareholders.
|
|
•
|
Manage corporate collateral and liquidity;
|
|
•
|
Effectively perform financial planning and reporting and full SEC compliance; and
|
|
•
|
Oversee our interactions with regulators, rating agencies and investor relations to ensure we have an open and transparent relationship with each.
|
|
•
|
Manage the underwriting portfolio to achieve the underwriting plan;
|
|
•
|
Oversee continued improvement in business development to increase and diversify the Company’s client base; and
|
|
•
|
Develop a three year reinsurance plan.
|
|
•
|
Manage the analysis and possible implementation of the strategic direction of the Irish operation;
|
|
•
|
Ensure transparent communication with the Central Bank of Ireland, head office and group Board of Directors; and
|
|
•
|
Provide strong leadership to Irish operations and Greenlight Re Innovations.
|
|
•
|
Provide legal advice and manage internal and external matters, including outside counsel, relating to all legal agreements and matters;
|
|
•
|
Ensure compliance with all applicable laws and regulations as well as various policies and procedures;
|
|
•
|
Support key strategic projects and initiatives by providing advice on legal strategy and risks associated with business operations; and
|
|
•
|
Provide advice to the Board and its committees to ensure maintenance of strong corporate governance standards.
|
|
•
|
We have an entrepreneurial culture which encourages employees to think like owners;
|
|
•
|
We offer a balance of compensation elements with the majority of compensation related to long-term performance;
|
|
•
|
We set reasonable bonus targets for executives and employees and require that certain performance metrics are achieved before bonuses will be paid;
|
|
•
|
The design of our quantitative bonus program provides for the calculation and payment of bonuses once business develops instead of based on the initial accounting of underwriting;
|
|
•
|
Our Compensation Committee has the discretion to make adjustments to the quantitative bonus pool due to significant deficiencies;
|
|
•
|
The structure of our quantitative bonus program rewards employees and NEOs based on the economic underwriting performance of the Company as compared to top line premium targets which could encourage excessive risk taking among employees to achieve such targets;
|
|
•
|
The structure of our quantitative bonus program provide that underwriting losses experienced in a year are carried forward and applied against future years’ underwriting profits before quantitative bonuses are awarded; and
|
|
•
|
All of the equity awards granted to employees under the Company’s stock incentive plan are generally subject to multi-year time vesting, which requires an employee to commit to a longer period of employment for such awards to be valuable.
|
|
Name and Principal Position
|
|
Year
|
|
Salary
($) |
|
Bonus
($) (1) |
|
Stock Awards
($) (2) |
|
Option Awards
($) (3) |
|
Non-Equity Incentive Plan Compensation
($) (4) |
|
All Other Compensation
($) (5) |
|
Total
($) |
|||||||
|
Simon Burton,
Chief Executive Officer |
|
2019
|
|
650,000
|
|
|
600,000
|
|
|
0
|
|
|
—
|
|
|
—
|
|
|
10,610
|
|
|
1,260,610
|
|
|
|
|
2018
|
|
650,000
|
|
|
600,000
|
|
|
0
|
|
|
—
|
|
|
—
|
|
|
10,610
|
|
|
1,260,610
|
|
|
|
|
2017
|
|
325,000
|
|
|
250,000
|
|
|
—
|
|
|
4,610,112
|
|
|
—
|
|
|
5,305
|
|
|
5,190,417
|
|
|
Tim Courtis,
Chief Financial Officer |
|
2019
|
|
422,000
|
|
|
80,000
|
|
|
475,000
|
|
|
—
|
|
|
27,920
|
|
|
10,610
|
|
|
1,015,530
|
|
|
|
|
2018
|
|
422,000
|
|
|
125,000
|
|
|
350,000
|
|
|
—
|
|
|
9,795
|
|
|
10,610
|
|
|
917,405
|
|
|
|
|
2017
|
|
422,000
|
|
|
120,000
|
|
|
475,000
|
|
|
—
|
|
|
48,687
|
|
|
10,610
|
|
|
1,076,297
|
|
|
Brendan Barry,
Chief Underwriting Officer |
|
2019
|
|
500,000
|
|
|
80,000
|
|
|
400,000
|
|
|
—
|
|
|
61,070
|
|
|
10,610
|
|
|
1,051,680
|
|
|
|
|
2018
|
|
500,000
|
|
|
430,000
|
|
|
400,000
|
|
|
—
|
|
|
21,425
|
|
|
10,610
|
|
|
1,362,035
|
|
|
|
|
2017
|
|
472,000
|
|
|
94,400
|
|
|
350,000
|
|
|
—
|
|
|
106,499
|
|
|
10,610
|
|
|
1,033,509
|
|
|
Patrick O’Brien,
Chief Executive Officer, GRIL (6) |
|
2019
|
|
358,208
|
|
|
100,746
|
|
|
285,000
|
|
|
—
|
|
|
—
|
|
|
71,642
|
|
|
815,596
|
|
|
|
|
2018
|
|
353,160
|
|
|
211,896
|
|
|
194,400
|
|
|
—
|
|
|
—
|
|
|
70,632
|
|
|
830,088
|
|
|
|
|
2017
|
|
341,070
|
|
|
102,321
|
|
|
116,827
|
|
|
—
|
|
|
—
|
|
|
68,214
|
|
|
628,432
|
|
|
Laura Accurso,
General Counsel and Corporate Secretary |
|
2019
|
|
390,000
|
|
|
200,000
|
|
|
250,000
|
|
|
—
|
|
|
25,935
|
|
|
10,610
|
|
|
876,545
|
|
|
|
|
2018
|
|
355,000
|
|
|
180,000
|
|
|
128,850
|
|
|
—
|
|
|
9,098
|
|
|
10,610
|
|
|
683,558
|
|
|
(1)
|
The amounts shown in this column for
2019
represent the discretionary portion of the NEO’s
2019
bonus paid on
March 13, 2020
. Additionally, for Mr. Barry the 2018 amount includes a $300,000 retention bonus paid to him on March 15, 2018.
|
|
(2)
|
All stock awards were granted under the our stock incentive plan. The value reported above in the “Stock Awards” column is the aggregate grant date fair value for each NEO’s award determined in accordance with FASB ASC Topic 718, “Compensation-Stock Compensation”. Assumptions used in the calculation of these amounts are included in Note 11 of the Notes to Consolidated Financial Statements in our Company’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2019
. The grant date fair value for Mr. Burton’s restricted share award in 2018 was computed in accordance with FASB ASC Topic 718 based upon the probable outcome that the performance conditions were not expected to be met as of the grant date. Assuming the highest level of performance achievement as of the grant date, the aggregate grant date value of the award would have been $487,500. The grant date fair value for Mr. Burton’s restricted share award in March
2019
was computed in accordance with FASB ASC Topic 718 based upon the probable outcome that the performance conditions were not expected to be met as of the grant date. Assuming the highest level of performance achievement as of the grant date, the aggregate grant date value of the award would have been $
975,000
. The grant date fair value for Mr. Burton’s restricted share award in September
2019
was computed in accordance with FASB ASC Topic 718 based upon the probable outcome that the performance conditions were not expected to be met as of the grant date. Assuming the highest level of performance achievement as of the grant date, the aggregate grant date value of the award would have been $2,500,000.
|
|
(3)
|
All option awards were granted under our stock incentive plan. The value reported above in the “Option Awards” column is the aggregate grant date fair value for the option awards granted in 2017, determined in accordance with FASB ASC Topic 718, “Compensation-Stock Compensation”. Assumptions used in the calculation of these amounts are included in Note 11 of the Notes to Consolidated Financial Statements in our Company’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2019
. The value reported for Mr. Burton relates to the grant of options issued to him in 2017 as a one-time special award in accordance with his employment agreement.
|
|
(4)
|
For the
2019
year, the value reported above in the “Non-Equity Incentive Plan Compensation” column is the amount paid to the applicable NEOs on
March 13, 2020
and relates to the
final installment
of the
2014 underwriting year
bonus. As discussed in the “Compensation Discussion and Analysis” section of this proxy statement, in 2012, our Compensation Committee amended the quantitative component of our bonus program to extend payment terms for underwriting years 2012 and beyond. After a two year transition commencing with the 2012 underwriting year, a quantitative bonus will be calculated and payable in three annual installments following the third, fourth and fifth years after the applicable underwriting year. Accordingly, quantitative bonuses are not earned in the year in which the business is underwritten, but rather, they are earned at the end of the applicable performance period.
|
|
(5)
|
The amounts shown in this column for
2019
include amounts contributed to the defined contribution plans in which our employees participate on behalf of each of Messrs. Burton, Courtis, Barry, and O’Brien and Ms. Accurso.
|
|
(6)
|
Because he is based in Ireland, Mr. O’Brien’s cash compensation is generally paid to him in Euros rather than United States dollars. Amounts reported as “Salary,” “Bonus,” and “All Other Compensation” are based on an average conversion rate for
2019
, which was $
1.1194
United States dollars for each Euro.
|
|
|
Grant Date
|
Approval Date
|
Estimated Future Payouts Under Non-Equity Incentive Plan Awards
|
Estimated Future Payouts Under Equity Incentive Plan Awards
|
All Other Stock Awards: Number of Shares of Stock or Units (#)
(5)
|
All Other Option Awards: Number of Securities Underlying Options (#)
|
Exercise or Base Price of Option Awards ($/Sh)
|
Grant Date Fair Value of Stock and Option Awards
($) (6) |
||||||||
|
|
|
|
|
Threshold (#)
|
Target/Maximum (#)
|
|
|
|
|
|||||||
|
Simon Burton
(3)
|
3/15/2019
|
2/19/2019
|
—
|
|
1
|
|
89,945
|
|
—
|
|
—
|
|
—
|
|
0
|
|
|
Simon Burton
(4)
|
9/22/2019
|
9/22/2019
|
—
|
|
—
|
|
236,295
|
|
—
|
|
—
|
|
—
|
|
0
|
|
|
Simon Burton
(1)
|
|
|
55,604
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
Simon Burton
(2)
|
|
|
2,500,000
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
Tim Courtis
|
3/15/2019
|
2/19/2019
|
—
|
|
—
|
|
—
|
|
43,819
|
|
—
|
|
—
|
|
475,000
|
|
|
Tim Courtis
(1)
|
|
|
7,521
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
Brendan Barry
|
3/15/2019
|
2/19/2019
|
—
|
|
—
|
|
—
|
|
36,900
|
|
—
|
|
—
|
|
400,000
|
|
|
Brendan Barry
(1)
|
|
|
20,272
|
|
|
|
|
|
|
—
|
|
|||||
|
Patrick O’Brien
|
3/15/2019
|
2/19/2019
|
—
|
|
—
|
|
—
|
|
26,292
|
|
—
|
|
—
|
|
285,000
|
|
|
Patrick O’Brien
(1)
|
|
|
12,113
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
Laura Accurso
|
3/15/2019
|
2/19/2019
|
—
|
|
—
|
|
—
|
|
23,063
|
|
—
|
|
—
|
|
250,000
|
|
|
Laura Accurso
(1)
|
|
|
6,950
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
(1)
|
The amounts reflect the NEO’s estimated quantitative bonus amounts with respect to the 2019 underwriting year, net of any applicable loss carry forward. The 2019 underwriting year result was negatively impacted by natural catastrophe events, however as of December 31, 2019, a small underwriting profit is expected.
|
|
(2)
|
The amount represents the cash bonus opportunity granted to Mr. Burton under the Bonus Agreement on September 22, 2019. Mr. Burton’s eligibility to receive the cash bonus is subject to, among other things, the Transaction Fee becoming due and payable (the date on which the Transaction Fee becomes due and payable, the “Fee Date”), Mr. Burton’s continuous employment in good standing until and on the Fee Date (and not having given notice of termination for any reason or received notice of termination for cause or due to disability), Mr. Burton signing and agreeing to be bound by a general release of claims and compliance by Mr. Burton with any and all confidentiality, non-competition, non-solicitation, non-disparagement and assignment of inventions provisions by which Mr. Burton may be bound through the Payment Date. If all conditions are satisfied, the cash bonus will be paid in a lump sum cash payment on the 60th day following the Fee Date (the “Payment Date”). If the Fee Date does not occur on or prior to December 15, 2020, the Bonus Agreement will automatically terminate.
|
|
(3)
|
The amount represents a grant on March 15, 2019 of restricted shares made pursuant to our stock incentive plan to Mr. Burton. Such restricted share award is subject to performance vesting conditions (i.e., the Combined Ratio) measured over the six year period from January 1, 2018 until December 31, 2023 and, subject to the terms and conditions of the award agreement, the earned shares, if any, will vest on March 15, 2024. The number of restricted shares earned, if any, is based on the cumulative all-in Combined Ratio for the Performance Period, as modified by the Adjusted Measurement, to the extent applicable, and is determined as follows: if the Combined Ratio is 97% or less, then Mr. Burton will earn all
89,945
restricted shares; if the Combined Ratio is above 97% and less than 102%, then the number of shares to be earned will be determined based on linear interpolation between the points; and if the Combined Ratio is 102% and higher then none of the restricted shares will be earned.
|
|
(4)
|
The amount represents a grant on September 22, 2019 of restricted shares made pursuant to our stock incentive plan to Mr. Burton. Mr. Burton’s eligibility for the restricted shares to vest is subject to, among other things, the Transaction
|
|
(5)
|
The amount represents a grant of restricted shares or restricted share units, as applicable, made pursuant to our stock incentive plan to each of Messrs. Courtis, Barry, and O’Brien and Ms. Accurso. Each such restricted share/restricted share unit award is subject to three-year cliff vesting.
|
|
(6)
|
The amounts reflect the aggregate grant date fair value for each NEO’s restricted share or restricted share unit awards granted in
2019
, determined in accordance with FASB ASC Topic 718, “Compensation—Stock Compensation”. The grant date fair value for Mr. Burton’s March 15, 2019 restricted share award was computed in accordance with FASB ASC Topic 718 based upon the probable outcome that the performance conditions were not expected to be met as of the grant date. Assuming the highest level of performance achievement as of the grant date, the aggregate grant date value of the award would have been $
975,000
. The grant date fair value for Mr. Burton’s September 22, 2019 restricted share award was computed in accordance with FASB ASC Topic 718 based upon the probable outcome that the performance conditions were not expected to be met as of the grant date. Assuming the highest level of performance achievement as of the grant date, the aggregate grant date value of the award would have been $2,500,000.
|
|
Option Awards
|
|
Stock Awards
|
|||||||||||||||||||||||||
|
Name
|
|
Number of Securities Underlying Unexercised Options Exercisable
(#) |
|
Number of Securities Underlying Unexercised Options Unexercisable (#)
|
|
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options
(#) |
|
Option Exercise Price
($) |
|
Option Expiration Date
|
|
Number of Shares or Units of Stock That Have Not Vested
(#) (1) |
|
Market Value of Shares or Units of Stock That Have Not Vested
($) (2) |
|
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested
(#) (1) |
|
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested
($) (2) |
|||||||||
|
Simon Burton
|
|
160,000
|
|
|
320,000
|
|
(3)
|
—
|
|
|
21.20
|
|
|
7/6/2027
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Simon Burton
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
356,900
|
|
(4) (5) (6)
|
3,608,259
|
|
|
Tim Courtis
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
87,772
|
|
(7)
|
887,375
|
|
|
—
|
|
|
—
|
|
|
Brendan Barry
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
78,223
|
|
(8)
|
790,835
|
|
|
—
|
|
|
—
|
|
|
Patrick O’Brien
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
45,280
|
|
(9)
|
457,781
|
|
|
—
|
|
|
—
|
|
|
Laura Accurso
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
34,862
|
|
(10)
|
352,455
|
|
|
—
|
|
|
—
|
|
|
(1)
|
Reflects grants of restricted shares and restricted share units made pursuant to our stock incentive plan. All restricted shares and restricted share units are subject to three-year cliff vesting, other than Mr. Burton’s restricted shares as noted below.
|
|
(2)
|
Assumes a stock price of
$10.11
, the closing price of the Class A ordinary shares on
December 31, 2019
, the last business day of the year.
|
|
(3)
|
Mr. Burton was granted an option to purchase 480,000 Class A ordinary shares on July 6, 2017 in accordance with the terms of his employment agreement. The option became exercisable with respect to 80,000 shares on June 30, 2018 and an additional 80,000 shares on June 30, 2019. The remaining portion of the option will become exercisable with
|
|
(4)
|
Mr. Burton was granted
30,660
Class A ordinary restricted shares on
March 15, 2018
subject (i) to performance vesting conditions (i.e., the Combined Ratio) measured over the five and one-half year period from July 1, 2017 until December 31, 2022 and (ii) generally to continued employment through and including the applicable vesting date (i.e., the fifth anniversary of the date of grant). The Combined Ratio will be determined after the end of the performance prior but prior to March 15, 2023. Accordingly, the actual number of shares earned will be determined following the end of the performance period. The numbers reflected with respect to this award assume achievement of the performance goals at the full target level.
|
|
(5)
|
Mr. Burton was granted
89,945
Class A ordinary restricted shares on
March 15, 2019
subject (i) to performance vesting conditions (i.e., the Combined Ratio) measured over the six year period from January 1, 2018 until December 31, 2023 and (ii) generally to continued employment through and including the applicable vesting date (i.e., the fifth anniversary of the date of grant). The Combined Ratio will be determined after the end of the performance prior but prior to March 15, 2024. Accordingly, the actual number of shares earned will be determined following the end of the performance period. The numbers reflected with respect to this award assume achievement of the performance goals at the full target level.
|
|
(6)
|
Mr. Burton was granted 236,295 Class A ordinary restricted shares on September 22, 2019. Mr. Burton’s eligibility for the restricted shares to vest is subject to, among other things, the Transaction Fee becoming due and payable, Mr. Burton’s continuous employment in good standing until the Vesting Time (and not having given notice of termination for any reason or received notice of termination for cause or due to disability), Mr. Burton signing and agreeing to be bound by a general release of claims and compliance by Mr. Burton with any and all confidentiality, non-competition, non-solicitation, non-disparagement and assignment of inventions provisions by which Mr. Burton may be bound through the Vesting Time. If all conditions are satisfied, the restricted shares will vest at the Vesting Time. If the Vesting Time does not occur on or prior to December 15, 2020, the unvested restricted shares will be automatically repurchased for par value and cancelled by the Company. The numbers reflected with respect to this award assume achievement of the performance goal.
|
|
(7)
|
Mr. Courtis was awarded
21,940
restricted shares on
March 15, 2017
,
22,013
restricted shares on
March 15, 2018
and
43,819
restricted shares on
March 15, 2019
. These restricted shares will vest on the third anniversary of each grant date, respectively, generally subject to his continued employment on each applicable vesting date.
|
|
(8)
|
Mr. Barry was awarded
16,166
restricted shares on
March 15, 2017
,
25,157
restricted shares on
March 15, 2018
and
36,900
restricted shares on
March 15, 2019
. These restricted shares will vest on the third anniversary of each grant date, respectively, generally subject to his continued employment on each applicable vesting date.
|
|
(9)
|
Mr. O’Brien was awarded
4,976
restricted share units on
March 15, 2017
,
14,012
restricted share units on
March 15, 2018
and
26,292
restricted share units on
March 15, 2019
. These restricted share units will vest on the third anniversary of the grant date, generally subject to his continued employment on each applicable vesting date.
|
|
(10)
|
Ms. Accurso was awarded
3,695
restricted shares on
March 15, 2017
,
8,104
restricted shares on
March 15, 2018
and
23,063
restricted shares on
March 15, 2019
. These restricted shares will vest on the third anniversary of each grant date, respectively, generally subject to her continued employment on each applicable vesting date.
|
|
|
|
Option Awards
|
|
Stock Awards
|
||||
|
Name
|
|
Number of Shares Acquired on Exercise (#)
|
|
Value Realized on Exercise ($)
(1)
|
|
Number of Shares Acquired On Vesting (#)
|
|
Value Realized on Vesting ($)
(2)
|
|
Simon Burton
|
|
—
|
|
—
|
|
—
|
|
—
|
|
Tim Courtis
|
|
—
|
|
—
|
|
27,539
|
|
301,277
|
|
Brendan Barry
|
|
—
|
|
—
|
|
20,292
|
|
221,994
|
|
Patrick O’Brien
|
|
—
|
|
—
|
|
—
|
|
—
|
|
Laura Accurso
|
|
—
|
|
—
|
|
3,711
|
|
40,598
|
|
(1)
|
Based upon the per share exercise price and the closing share price on the date of exercise.
|
|
(2)
|
Based upon the closing share price (
$10.94
) on the date upon which the shares fully vested (
March 15, 2019
).
|
|
•
|
misconduct on the part of the NEO so serious that we cannot reasonably be expected to take any action other than termination;
|
|
•
|
further misconduct on the part of the NEO within 12 months of the issue of a formal written warning in respect of misconduct so serious that we cannot reasonably be expected to tolerate any repetition thereof; and
|
|
•
|
a failure by the NEO to commence performance of his or her duties in a satisfactory manner within one month of the issue of a formal written warning in respect thereof.
|
|
•
|
habitual drug or alcohol use which impairs the ability of the NEO to perform his or her duties (other than where such drug is prescribed by and administered in accordance with the instructions of a qualified physician);
|
|
•
|
commission of a criminal offense in the course of employment (other than a minor traffic offense);
|
|
•
|
willful violation of the restrictive covenants set forth in the employment agreement;
|
|
•
|
willful failure or refusal to perform duties after a written demand for performance is delivered to the NEO by our Board of Directors that specifically identifies the manner in which our Board of Directors believes that the NEO has failed or refused to perform his or her duties; and
|
|
•
|
breach of any material provision of the employment agreement or any policies of the employer entities or any of their affiliates related to conduct which is not cured, if curable, within ten days after written notice.
|
|
•
|
the NEO’s drug or alcohol use which impairs his ability to perform his duties;
|
|
•
|
conviction by a court, or plea of “no contest” or guilty to a criminal offense;
|
|
•
|
engaging in fraud, embezzlement or any other illegal conduct with respect to us and/or any of our affiliates;
|
|
•
|
willful violation of the restrictive covenants set forth in his employment agreement;
|
|
•
|
willful failure or refusal to perform the duties under his employment agreement; or
|
|
•
|
breach of any material provision of his employment agreement or any of our or any of our affiliates’ policies related to conduct which is not cured, if curable, within ten days after written notice is given.
|
|
•
|
any material and adverse change to the NEO’s duties which is inconsistent with his duties set forth in the employment agreement (or, in the case of Mr. Burton and Ms. Accurso, his or her title or duties);
|
|
•
|
a reduction of the NEO’s base salary; or
|
|
•
|
a failure by us to comply with any other material provisions of the employment agreement.
|
|
•
|
is guilty of dishonesty or other gross misconduct or gross incompetence or willful neglect of duty or commits any other serious breach of his employment agreement;
|
|
•
|
acts in any manner (whether in the course of his duties or otherwise) which is likely to bring him, GRIL or us into disrepute or prejudice our or GRIL’s interests;
|
|
•
|
becomes bankrupt, the subject of a debt resolution notice, applies for or have made against him a receiving order, or has any order made against him resulting in a voluntary arrangement or personal insolvency;
|
|
•
|
is or becomes of unsound mind;
|
|
•
|
for an aggregate period of 120 days or more in any period of 12 consecutive months is incapable of performing his duties under his employment agreement by reason of ill health or other incapacity (whether accidental or otherwise);
|
|
•
|
is guilty of continuing unsatisfactory conduct or poor performance of his duties after warning from us relating to the same;
|
|
•
|
is arrested for, charged with or convicted of any offense other than an offense which in the reasonable opinion of the Board of Directors of GRIL does not affect his position with GRIL;
|
|
•
|
resigns as a director of the Company or GRIL without our or GRIL’s consent;
|
|
•
|
is subject to a restriction or is disqualified or prohibited by law from being a director of GRIL;
|
|
•
|
breaches any material provision in his employment agreement or any of our policies or the policies of GRIL;
|
|
•
|
uses drugs or alcohol which impairs his ability to perform his duties under the employment agreement; or
|
|
•
|
the Central Bank of Ireland issues a notice to him either suspending him or prohibiting him from acting in his position with the Company.
|
|
•
|
material breach of his or her employment agreement or other agreement;
|
|
•
|
continued failure to satisfactorily perform assigned job responsibilities or to follow the reasonable instructions of his or her superiors, including, without limitation, our Board of Directors;
|
|
•
|
commission of a crime constituting a criminal offense or felony (or its equivalent) or other crime involving moral turpitude; or
|
|
•
|
material violation of any material law or regulation or any policy or code of conduct adopted by us or engaging in any other form of misconduct which, if it were made public, could reasonably be expected to adversely affect our or an affiliate’s business reputation or affairs.
|
|
Event
|
|
Pro-Rated Bonus
(8)
$ |
|
Total Cash Severance
$ |
|
Value of Medical Continuation
$ |
|
Value of Accelerated Equity
$ |
|
Other Bonus $
|
|
Total
$ |
|||||
|
Termination without Cause or non-renewal of the employment term by the Company
(1)
|
|
780,000
|
|
|
1,430,000
|
|
|
N/A
|
|
—
|
|
|
—
|
|
|
2,210,000
|
|
|
Termination for Good Reason
(2)
|
|
780,000
|
|
|
1,430,000
|
|
|
N/A
|
|
—
|
|
|
—
|
|
|
2,210,000
|
|
|
Death
(3)
|
|
780,000
|
|
|
N/A
|
|
|
N/A
|
|
—
|
|
|
—
|
|
|
780,000
|
|
|
Disability
(4)
|
|
780,000
|
|
|
N/A
|
|
|
N/A
|
|
—
|
|
|
—
|
|
|
780,000
|
|
|
Change of Control
(5) (6)
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
2,388,942
|
|
|
2,500,000
|
|
|
4,888,942
|
|
|
Satisfaction of Retirement Conditions throughout the Performance Period
(7)
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
—
|
|
|
N/A
|
|
|
—
|
|
|
(1)
|
The Total Cash Severance is calculated as the sum of base salary (
$650,000
) and target bonus (
$780,000
). No amounts are reported in respect of the 30,660 and 89,945 restricted shares granted on
March 15, 2018
and
March 15, 2019
, respectively, which would remain outstanding and eligible to vest subject to the performance vesting provisions in connection with a termination by the Company without cause (including the Company’s election to not renew the then current term of the employment agreement generally on equivalent terms upon expiration of such term), as the performance period has not concluded and, therefore, it cannot be determined as to whether the shares will vest. No
|
|
(2)
|
The Total Cash Severance is calculated as the sum of base salary (
$650,000
) and target bonus (
$780,000
). No amounts are reported in respect of the 30,660 and 89,945 restricted shares granted on
March 15, 2018
and
March 15, 2019
, respectively, which would remain outstanding and eligible to vest subject to the performance vesting provisions in connection with a termination by Mr. Burton for good reason prior to the vesting date, as the performance period has not concluded and, therefore, it cannot be determined as to whether the shares will vest.
|
|
(3)
|
No amounts are reported in respect of the 30,660 and 89,945 restricted shares granted on
March 15, 2018
and
March 15, 2019
, respectively, which would remain outstanding and eligible to vest subject to the performance vesting provisions in connection with a termination due to death prior to the vesting date, as the performance period has not concluded and, therefore, it cannot be determined as to whether the shares will vest.
|
|
(4)
|
No amounts are reported in respect of the 30,660 and 89,945 restricted shares granted on
March 15, 2018
and
March 15, 2019
, respectively, which would remain outstanding and eligible to vest subject to the performance vesting provisions in connection with a termination due to disability prior to the vesting date, as the performance period has not concluded and, therefore, it cannot be determined as to whether the shares will vest.
|
|
(5)
|
The amount reported reflects the vesting of the restricted shares granted on September 22, 2019, assuming the conditions are satisfied, which amount is calculated as the fair market value of the 236,295 restricted shares subject to vesting assuming the Transaction Fee became due and payable on
December 31, 2019
and using a share price of
$10.11
, the closing share price on
December 31, 2019
, the last business day of the year. No amounts are reported in respect of the vesting in connection with a change of control of the options granted on July 1, 2017 as there was no “spread” value with respect to such options (i.e., the exercise price exceeded the fair market value on
December 31, 2019
, the last business day of the year).
|
|
(6)
|
The amount reported reflects the cash bonus under the Bonus Agreement that will become payable as a result of the Transaction Fee becoming due and payable, assuming the other conditions have been satisfied.
|
|
(7)
|
No amounts are reported in respect of the 30,660 and 89,945 restricted shares granted on
March 15, 2018
and
March 15, 2019
, respectively, which would remain outstanding and eligible to vest subject to the performance vesting provisions as result of the satisfaction of the retirement conditions throughout the performance period as the performance period has not concluded and, therefore, it cannot be determined as to whether the shares will vest.
|
|
(8)
|
The Pro-Rated Bonus is calculated as
120%
of base salary.
|
|
Event
|
|
Pro-Rated Bonus
(3)
$ |
|
Total Cash Severance
$ |
|
Value of Medical Continuation
$ |
|
Value of Accelerated Equity
(4)
$ |
|
Total
$ |
|||||
|
Termination without Cause or for Good Reason
(1)
|
|
211,000
|
|
|
658,000
|
|
|
N/A
|
|
|
N/A
|
|
|
869,000
|
|
|
Death
|
|
211,000
|
|
|
N/A
|
|
|
29,325
|
|
|
887,375
|
|
|
1,127,700
|
|
|
Disability
(2)
|
|
211,000
|
|
|
422,000
|
|
|
29,325
|
|
|
887,375
|
|
|
1,549,700
|
|
|
Change in Control
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
887,375
|
|
|
887,375
|
|
|
(1)
|
The Total Cash Severance is calculated as the sum of base salary (
$422,000
) and target bonus (
$211,000
) plus an additional
$25,000
for relocation expenses.
|
|
(2)
|
The Total Cash Severance is calculated as 100% of base salary.
|
|
(3)
|
The Pro-Rated Bonus is calculated as 50% of base salary.
|
|
(4)
|
The Value of Accelerated Equity is calculated as the fair market value of the
87,772
restricted shares subject to accelerated vesting if a termination due to death or disability or a change in control occurred, in each case, on
|
|
Event
|
|
Pro-Rated Bonus
(4)
$ |
|
Total Cash Severance
$ |
|
Value of Medical Continuation
$ |
|
Value of Accelerated Equity
(5)
$ |
|
Total
$ |
|||||
|
Termination without Cause or for Good Reason
(1)
|
|
325,000
|
|
|
825,000
|
|
|
N/A
|
|
|
N/A
|
|
|
1,150,000
|
|
|
Termination without Good Reason
(2)
|
|
N/A
|
|
|
250,000
|
|
|
N/A
|
|
|
N/A
|
|
|
250,000
|
|
|
Death
|
|
325,000
|
|
|
N/A
|
|
|
29,325
|
|
|
790,835
|
|
|
1,145,160
|
|
|
Disability
(3)
|
|
325,000
|
|
|
500,000
|
|
|
29,325
|
|
|
790,835
|
|
|
1,645,160
|
|
|
Change in Control
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
790,835
|
|
|
790,835
|
|
|
(1)
|
The Total Cash Severance is calculated as the sum of base salary (
$500,000
) and target bonus (
$325,000
) in connection with a Termination without Cause or for Good Reason.
|
|
(2)
|
The Total Cash Severance is calculated as 50% of base salary.
|
|
(3)
|
The Total Cash Severance is calculated as 100% of base salary.
|
|
(4)
|
The Pro-Rated Bonus is calculated as
65%
of base salary.
|
|
(5)
|
The Value of Accelerated Equity is calculated as the fair market value of the
78,223
restricted shares subject to accelerated vesting if a termination due to death or disability or a change in control occurred, in each case, on
December 31, 2019
and using a share price of
$10.11
, the closing share price on
December 31, 2019
, the last business day of the year.
|
|
Event
(2)
|
|
Pro-Rated Bonus
(3)
$ |
|
Total Cash Severance
$ |
|
Value of Medical Continuation
$ |
|
Value of Accelerated Equity
(4)
$ |
|
Total
$ |
||||
|
Termination with prior notice
(1)
|
|
214,925
|
|
|
573,133
|
|
|
N/A
|
|
N/A
|
|
|
788,058
|
|
|
Death
|
|
214,925
|
|
|
N/A
|
|
|
N/A
|
|
457,781
|
|
|
672,706
|
|
|
Disability
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
457,781
|
|
|
457,781
|
|
|
Change in Control
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
457,781
|
|
|
457,781
|
|
|
(1)
|
The Total Cash Severance is calculated as the sum of base salary (
$358,208
) and target bonus (
$214,925
).
|
|
(2)
|
As Mr. O’Brien is based in Ireland, his cash compensation is generally paid to him in Euros rather than United States dollars. The Total Cash Severance is based on an average conversion rate for
2019
, which was
$1.1194
United States dollars per Euro.
|
|
(3)
|
The Pro-Rated Bonus is calculated as
60%
of base salary.
|
|
(4)
|
The Value of Accelerated Equity is calculated as the fair market value of the
45,280
restricted share units subject to accelerated vesting if a termination due to death or disability or a change in control occurred, in each case, on
December 31, 2019
and using a share price of
$10.11
, the closing share price on
December 31, 2019
, the last business day of the year.
|
|
Event
|
|
Pro-Rated Bonus
(2)
$ |
|
Total Cash Severance
$ |
|
Value of Medical Continuation
$ |
|
Value of Accelerated Equity
(3)
$ |
|
Total
$ |
|||||
|
Termination without Cause or for Good Reason
(1)
|
|
195,000
|
|
|
585,000
|
|
|
14,663
|
|
|
352,455
|
|
|
1,147,118
|
|
|
Termination without Good Reason
|
|
N/A
|
|
|
N/A
|
|
|
14,663
|
|
|
N/A
|
|
|
14,663
|
|
|
Death
|
|
195,000
|
|
|
N/A
|
|
|
14,663
|
|
|
352,455
|
|
|
562,118
|
|
|
Disability
|
|
195,000
|
|
|
N/A
|
|
|
14,663
|
|
|
352,455
|
|
|
562,118
|
|
|
Change in Control
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
352,455
|
|
|
352,455
|
|
|
(1)
|
The Total Cash Severance is calculated as the sum of base salary (
$390,000
) and target bonus (
$195,000
).
|
|
(2)
|
The Pro-Rated Bonus is calculated as
50%
of base salary.
|
|
(3)
|
The Value of Accelerated Equity is calculated as the fair market value of the
34,862
restricted shares subject to the accelerated vesting if a termination due to death or disability or a change in control occurred, in each case, on
December 31, 2019
and using a share price of
$10.11
, the closing share price on
December 31, 2019
, the last business date of the year. In connection with a termination by the Company without cause or by Ms. Accurso for good reason where the awards are not cancelled and remain subject to the vesting conditions, the amount reflected above assumes that the fair market value on the actual date of vesting is the same as the closing share price on
December 31, 2019
.
|
|
i.
|
We selected
December 31, 2019
(the “determination date”), which is within the last three months of
2019
, as the date upon which we would identify the “median employee.”
|
|
ii.
|
We identified the median employee by examining the annual total compensation for
2019
, calculated in accordance with the requirements of Item 402(c)(2)(x) of Regulation S-K, of each of our employees employed as of
December 31, 2019
. For those employees who joined the Company during
2019
the total compensation was annualized as if they had been employed for the entire year. We calculated the total compensation for each employee in the same manner as the “Total Compensation” shown for our NEOs in the “Summary Compensation Table”, including converting currencies of our employees in Ireland into United States dollars based on an average conversion rate for
2019
which was $
1.1194
. We determined the compensation of our median employee by ranking the annual total compensation of all employees, except for our CEO, and selecting the median employee based on their total compensation.
|
|
Plan category
|
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights
|
|
Weighted-average exercise price of outstanding options, warrants and rights
|
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
|
|
||||
|
|
|
(a)
|
|
(b)
|
|
(c)
|
|
||||
|
Equity compensation plans approved by security holders
|
|
875,627
|
|
(1)
|
$
|
22.68
|
|
|
555,805
|
|
(2)
|
|
Equity compensation plans not approved by security holders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
Total
|
|
875,627
|
|
(1)
|
$
|
22.68
|
|
|
555,805
|
|
(2)
|
|
(1)
|
Includes
875,627
Class A ordinary shares issuable upon the exercise of options and restricted share units that were outstanding under the stock incentive plan as of
December 31, 2019
.
|
|
(2)
|
Represents the difference between the number of securities issuable under the stock incentive plan (
5,000,000
) and the number of securities issued under the stock incentive plan as of
December 31, 2019
(
4,444,195
). The number of securities issued under the stock incentive plan consists of options to acquire
2,054,627
Class A ordinary shares and
2,389,568
issued shares or share units.
|
|
•
|
each person or group who beneficially owns more than 5% of each class of our ordinary shares;
|
|
•
|
each of our NEOs, Messrs. Burton, Courtis, Barry, O’Brien and Accurso;
|
|
•
|
each of our directors; and
|
|
•
|
all of our directors and NEOs as a group.
|
|
Name and address of beneficial owner
|
|
Beneficial ownership of principal shareholders
|
||||||||||
|
|
|
Number of Class A Ordinary Shares
|
|
%
|
|
Number of Class B Ordinary Shares
|
|
%
|
||||
|
David Einhorn
|
(1)
|
—
|
|
|
—
|
%
|
|
6,254,715
|
|
|
100.00
|
%
|
|
Blackrock, Inc.
|
(2)
|
2,368,472
|
|
|
8.07
|
%
|
|
|
|
|
||
|
Dimensional Fund Advisors LP
|
(3)
|
2,063,214
|
|
|
7.03
|
%
|
|
|
|
|
||
|
The Vanguard Group
|
(4)
|
1,944,208
|
|
|
6.62
|
%
|
|
|
|
|
||
|
Morgan Stanley
|
(5)
|
1,889,289
|
|
|
6.43
|
%
|
|
|
|
|
||
|
Davis Selected Advisers, L.P.
|
(6)
|
1,860,842
|
|
|
6.34
|
%
|
|
|
|
|
||
|
Sirius International Insurance Group, Ltd.
|
(7)
|
1,520,000
|
|
|
5.18
|
%
|
|
|
|
|
||
|
Simon Burton
|
(8)
|
741,989
|
|
|
2.51
|
%
|
|
|
|
|
||
|
Tim Courtis
|
(9)
|
421,449
|
|
|
1.44
|
%
|
|
|
|
|
||
|
Brendan Barry
|
|
68,389
|
|
|
*
|
|
|
|
|
|
||
|
Patrick O'Brien
|
(10)
|
4,976
|
|
|
*
|
|
|
|
|
|
||
|
Laura Accurso
|
(11)
|
85,426
|
|
|
*
|
|
|
|
|
|
||
|
Alan Brooks
|
|
147,401
|
|
|
*
|
|
|
|
|
|
||
|
Leonard Goldberg
|
(12)
|
265,877
|
|
|
*
|
|
|
|
|
|
||
|
Ian Isaacs
|
(13)
|
108,946
|
|
|
*
|
|
|
|
|
|
||
|
Frank Lackner
|
(14)
|
124,824
|
|
|
*
|
|
|
|
|
|
||
|
Bryan Murphy
|
|
99,722
|
|
|
*
|
|
|
|
|
|
||
|
Joseph Platt
|
(15)
|
161,145
|
|
|
*
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||||
|
All directors and executive officers as a group (12 persons)
|
|
2,230,144
|
|
|
7.52
|
%
|
|
6,254,715
|
|
|
100.00
|
%
|
|
*
|
Represents less than 1% of the outstanding ordinary shares.
|
|
(1)
|
Mr. Einhorn, together with his affiliates, is limited to voting the number of Class B ordinary shares equal to 9.5% of the total voting power of the total issued and outstanding ordinary shares. Mr. Einhorn owns
4,864,227
Class B ordinary shares directly. Mr. Einhorn also retains beneficial ownership of
1,390,488
Class B ordinary shares held by the David M. Einhorn 2007 Family Trust. Mr. Einhorn has appointed Mr. Roitman as his alternate director. Mr. Roitman has beneficial ownership of
325,000
Class A ordinary shares. If Mr. Roitman’s Class A ordinary shares were included in the total shares held by the directors and NEOs, such number would be
2,555,144
shares, or
8.62%
.
|
|
(2)
|
BlackRock, Inc.’s beneficial ownership is based on a Schedule 13G/A filed on February 5, 2020. The business address for BlackRock Inc. is 55 East 52nd Street, New York, NY 10022.
|
|
(3)
|
Dimensional Fund Advisors LP’s beneficial ownership is based on a Schedule 13G filed on February 12, 2020. The business address for Dimensional Fund Advisors LP is Building One, 6300 Bee Cave Road, Austin, Texas, 78746.
|
|
(4)
|
The Vanguard Group’s beneficial ownership is based on a Schedule 13G/A filed on February 12, 2020. The business address for The Vanguard Group is 100 Vanguard Blvd., Malvern, PA19355.
|
|
(5)
|
Morgan Stanley’s beneficial ownership is based on a Schedule 13G/A filed on February 12, 2020. The business address for Morgan Stanley is 1585 Broadway New York, NY 10036.
|
|
(6)
|
Davis Selected Advisers, L.P.’s beneficial ownership is based on a Schedule 13G/A filed on February 13, 2020. The business address for Davis Selected Advisers, L.P. is 2949 East Elvira Road, Suite 101, Tucson, Arizona 85756.
|
|
(7)
|
Sirius International Insurance Group Ltd.’s beneficial ownership is based on a Schedule 13G/A filed on June 13, 2019. The business address for Sirius International Insurance Group Ltd. is 14 Wesley Street, 5th Floor, Hamilton HM 11, Bermuda.
|
|
(8)
|
Includes 429,444 restricted shares subject to performance conditions and forfeiture. In addition, Mr. Burton owns options to purchase 480,000 Class A ordinary shares, which options vest in six equal annual installments beginning on the first anniversary following the grant date of June 30, 2017. 240,000 options are currently exercisable or exercisable within 60 days of
September 8, 2020
.
|
|
(9)
|
Includes 95,594 restricted shares subject to forfeiture.
|
|
(10)
|
Mr. O’Brien also owns 81,599 restricted share units. Since these restricted share units do not have any voting or disposition rights until they vest and none vest within 60 days of
September 8, 2020
, these shareholdings are not reported.
|
|
(11)
|
Includes 73,578 restricted shares subject to forfeiture.
|
|
(12)
|
Includes
42,250
Class A ordinary shares subject to options held by Mr. Goldberg. Mr. Goldberg owns 176,757 Class A ordinary shares directly and also retains beneficial ownership of 22,870 Class A ordinary shares held by the Leonard R. Goldberg 2007 Family Trust and 24,000 Class A ordinary shares held in a spousal revocable trust.
|
|
(13)
|
Includes 25,000 Class A ordinary shares held by a living trust and 25,000 Class A ordinary shares held in an IRA. Mr. Isaacs has pledged 51,154 Class A ordinary shares of his unrestricted shares.
|
|
(14)
|
Mr. Lackner has pledged 107,868 Class A ordinary shares of his unrestricted shares.
|
|
(15)
|
Includes 55,000 Class A ordinary shares held by a partnership of which Mr. Platt is the general partner.
|
|
|
By Order of the Board of Directors,
|
|
|
/s/ Simon Burton
|
|
|
Simon Burton
|
|
|
Chief Executive Officer
|
|
|
September 8, 2020
|
|
|
Grand Cayman, Cayman Islands
|
|
1.
|
Purposes
.
|
|
2.
|
Definitions
.
|
|
3.
|
Administration
.
|
|
4.
|
Shares Subject to the Plan
.
|
|
5.
|
Eligibility
.
|
|
6.
|
Option Provisions
.
|
|
7.
|
Provisions of Awards Other Than Options
.
|
|
8.
|
Covenants of the Company.
|
|
9.
|
Use of Proceeds from Stock
.
|
|
10.
|
Miscellaneous
.
|
|
11.
|
Adjustments Upon Changes in Stock
.
|
|
12.
|
Amendment of the Plan and Awards
.
|
|
13.
|
Termination or Suspension of the Plan
.
|
|
14.
|
Effective Date of Plan
.
|
|
15.
|
Choice of Law
.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|